1,099
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis

, , &

References

  • Abenavoli, L., E. Scarpellini, C. Colica, L. Boccuto, B. Salehi, J. Sharifi-Rad, V. Aiello, B. Romano, A. De Lorenzo, A. A. Izzo, et al. 2019. Gut microbiota and obesity: A role for probiotics. Nutrients 11 (11):2690. doi: 10.3390/nu11112690.
  • Aguiar, C., E. Alegria, R. C. Bonadonna, A. L. Catapano, F. Cosentino, M. Elisaf, M. Farnier, J. Ferrières, P. P. Filardi, N. Hancu, et al. 2015. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. Atherosclerosis Supplements 19:1–12. doi: 10.1016/S1567-5688(15)30001-5.
  • Ahmadi, S., M. Jamilian, M. Karamali, M. Tajabadi-Ebrahimi, P. Jafari, M. Taghizadeh, M. R. Memarzadeh, and Z. Asemi. 2017. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Human Fertility (Cambridge, England) 20 (4):254–61. doi: 10.1080/14647273.2017.1283446.
  • Ahmadi, S., R. Nagpal, S. Wang, J. Gagliano, D. W. Kitzman, S. Soleimanian-Zad, M. Sheikh-Zeinoddin, R. Read, and H. Yadav. 2019. Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome-gut-brain axis modulation. The Journal of Nutritional Biochemistry 67:1–13. doi: 10.1016/j.jnutbio.2019.01.011.
  • Andersson, U., C. Bränning, S. Ahrné, G. Molin, J. Alenfall, G. Onning, M. Nyman, and C. Holm. 2010. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Beneficial Microbes 1 (2):189–96. doi: 10.3920/BM2009.0036.
  • Araya, M., L. Morelli, G. Reid, Sanders ME, Stanton C, Pineiro M, Ben Embarek P. 2002. Guidelines for the evaluation of probiotics in food. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada. http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
  • Azziz, R., E. Carmina, Z. Chen, A. Dunaif, J. S. Laven, R. S. Legro, D. Lizneva, B. Natterson-Horowtiz, H. J. Teede, and B. O. Yildiz. 2016. Polycystic ovary syndrome. Nature Reviews. Disease Primers 2:16057. doi: 10.1038/nrdp.2016.57.
  • Bock, P. M., G. H. Telo, R. Ramalho, M. Sbaraini, G. Leivas, A. F. Martins, and B. D. Schaan. 2021. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: A systematic review and meta-analysis. Diabetologia 64 (1):26–41. doi: 10.1007/s00125-020-05295-1.
  • Breton, J., N. Tennoune, N. Lucas, M. Francois, R. Legrand, J. Jacquemot, A. Goichon, C. Guerin, J. Peltier, M. Pestel-Caron, et al. 2016. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metabolism 23 (2):324–34. doi: 10.1016/j.cmet.2015.10.017.
  • Cani, P. D., and N. M. Delzenne. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 15 (13):1546–58. doi: 10.2174/138161209788168164.
  • Champagne, C. P., R. P. Ross, M. Saarela, K. F. Hansen, and D. Charalampopoulos. 2011. Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. International Journal of Food Microbiology 149 (3):185–93. doi: 10.1016/j.ijfoodmicro.2011.07.005.
  • Chapman, M. J., H. N. Ginsberg, P. Amarenco, F. Andreotti, J. Borén, A. L. Catapano, O. S. Descamps, E. Fisher, P. T. Kovanen, J. A. Kuivenhoven, et al. 2011. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovas-cular disease: Evidence and guidance for management. European Heart Journal 32 (11):1345–61. doi: 10.1093/eurheartj/ehr112.
  • Chen, Y., Z. Minghui, and W. Channi. 2018. Effect of probiotic supplementation on blood sugar and lipids in patients with polycystic ovary syndrome. International Journal of Gynecology & Obstetrics 45 (2):199–202.
  • Coutinho, E. A., and A. S. Kauffman. 2019. The role of the brain in the pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS). Medical Sciences 7 (8):84. doi: 10.3390/medsci7080084.
  • Cozzolino, M., A. Vitagliano, L. Pellegrini, M. Chiurazzi, A. Andriasani, G. Ambrosini, and N. Drabińska, E. Jarocka-Cyrta, L. H. Markiewicz, and U. Krupa-Kozak. 2018. The effect of oligofructose-enriched inulin on faecal bacterial counts and microbiota-associated characteristics in celiac disease children following a gluten-free diet: Results of a randomized, placebo-controlled trial. Nutrients 10 (2):201. doi: 10.3390/nu10020201.
  • Cozzolino, M., A. Vitagliano, L. Pellegrini, M. Chiurazzi, A. Andriasani, G. Ambrosini, and N. Garrido. 2020. Therapy with probiotics and synbiotics for polycystic ovarian syndrome: A systematic review and meta-analysis. European Journal of Nutrition 59 (7):2841–56. doi: 10.1007/s00394-020-02233-0.
  • Eshre TR GASP. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81 (1):19–25. doi: 10.1016/j.fertnstert.2003.10.004.
  • Esmaeilinezhad, Z., S. Babajafari, Z. Sohrabi, M. H. Eskandari, S. Amooee, and R. Barati-Boldaji. 2019. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutrition, Metabolism, and Cardiovascular Diseases 29 (2):201–8. doi: 10.1016/j.numecd.2018.07.002.
  • Fauser, B. C., B. C. Tarlatzis, R. W. Rebar, R. S. Legro, A. H. Balen, R. Lobo, E. Carmina, J. Chang, B. O. Yildiz, J. S. Laven, et al. 2012. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 97 (1):28–38. doi: 10.1016/j.fertnstert.2011.09.024.
  • Ferrarese, R., E. R. Ceresola, A. Preti, and F. Canducci. 2018. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. European Review for Medical and Pharmacological Sciences 22 (21):7588–605. doi: 10.26355/eurrev_201811_16301.
  • Firouzi, S., H. A. Majid, A. Ismail, N. A. Kamaruddin, and M. Y. Barakatun-Nisak. 2017. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: A randomized controlled trial. European Journal of Nutrition 56 (4):1535–50. doi: 10.1007/s00394-016-1199-8.
  • Ghanei, N., N. Rezaei, G. A. Amiri, F. Zayeri, G. Makki, and E. Nasseri. 2018. The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Functional Foods 42:306–11. doi: 10.1016/j.jff.2017.12.047.
  • Gibson, G. R., R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, K. Scott, C. Stanton, K. S. Swanson, P. D. Cani, et al. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology 14 (8):491–502. doi: 10.1038/nrgastro.2017.75.
  • Goodarzi, M. O., D. A. Dumesic, G. Chazenbalk, and R. Azziz. 2011. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews Endocrinology 7 (4):219–31. doi: 10.1038/nrendo.2010.217.
  • Gunning, M. N., T. Sir Petermann, N. Crisosto, B. B. van Rijn, M. A. de Wilde, J. P. Christ, C. Uiterwaal, W. de Jager, M. Eijkemans, A. R. Kunselman, et al. 2020. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: A systematic review and individual participant data meta-analysis. Human Reproduction Update 26 (1):103–17. doi: 10.1093/humupd/dmz036.
  • Gurung, M., Z. Li, H. You, R. Rodrigues, D. B. Jump, A. Morgun, and N. Shulzhenko. 2020. Role of gut microbiota in type 2 diabetes pathophysiology. EbioMedicine 51:102590. doi: 10.1016/j.ebiom.2019.11.051.
  • Hadi, A., S. Moradi, A. Ghavami, S. Khalesi, and M. Kafeshani. 2020. Effect of probiotics and synbiotics on selected anthropometric and biochemical measures in women with polycystic ovary syndrome: A systematic review and meta-analysis. European Journal of Clinical Nutrition 74 (4):543–7. doi: 10.1038/s41430-019-0434-9.
  • Hendijani, F., and V. Akbari. 2018. Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: A systematic review and meta-analysis. Clinical Nutrition (Edinburgh, Scotland) 37 (2):532–41. doi: 10.1016/j.clnu.2017.02.015.
  • Heshmati, J., F. Farsi, S. Yosaee, M. Razavi, M. Rezaeinejad, E. Karimie, and M. Sepidarkish. 2019. The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: A systematic review and meta-analysis of randomized clinical trials. Probiotics and Antimicrobial Proteins 11 (4):1236–47. doi: 10.1007/s12602-018-9493-9.
  • Higgins, J. P. T., J. Thomas, J. Chandler, M. Cumpston, T. Li, MJ. Page, and V. A. Welch, eds. 2019. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Chichester (UK): John Wiley & Sons. www.training.cochrane.org/handbook.
  • Holscher, H. D. 2017. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8 (2):172–84. doi: 10.1080/19490976.2017.1290756.
  • Homayoni Rad, A., E. V. Mehrabany, B. Alipoor, L. V. Mehrabany, and M. Javadi. 2012. Do probiotics act more efficiently in foods than in supplements? Nutrition 28 (7–8):733–6. doi: 10.1016/j.nut.2012.01.012.
  • Insenser, M., M. Murri, R. Del Campo, M. Á. Martínez-García, E. Fernández-Durán, and H. F. Escobar-Morreale. 2018. Gut microbiota and the polycystic ovary syndrome: Influence of sex, sex hormones, and obesity. The Journal of Clinical Endocrinology & Metabolism 103 (7):2552–62. doi: 10.1210/jc.2017-02799.
  • Jamilian, M., S. Mansury, F. Bahmani, Z. Heidar, E. Amirani, and Z. Asemi. 2018. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. Journal of Ovarian Research 11 (1):80. doi: 10.1186/s13048-018-0457-1.
  • Jiao, N., S. S. Baker, C. A. Nugent, M. Tsompana, L. Cai, Y. Wang, M. J. Buck, R. J. Genco, R. D. Baker, R. Zhu, et al. 2018. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: A meta-analysis. Physiological Genomics 50 (4):244–54. doi: 10.1152/physiolgenomics.00114.2017.
  • Jumpertz, R., D. S. Le, P. J. Turnbaugh, C. Trinidad, C. Bogardus, J. I. Gordon, and J. Krakoff. 2011. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. The American Journal of Clinical Nutrition 94 (1):58–65. doi: 10.3945/ajcn.110.010132.
  • Karamali, M., S. Eghbalpour, S. Rajabi, M. Jamilian, F. Bahmani, M. Tajabadi-Ebrahimi, F. Keneshlou, S. M. Mirhashemi, M. Chamani, G. S. Hashem, et al. 2018. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Archives of Iranian Medicine 21 (1):1–7.
  • Karimi, E., J. Heshmati, N. Shirzad, S. Vesali, M. J. Hosseinzadeh-Attar, A. Moini, and M. Sepidarkish. 2020. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: A randomized controlled trial. Lipids in Health and Disease 19 (1):60. doi: 10.1186/s12944-020-01244-4.
  • Karimi, E., A. Moini, M. Yaseri, N. Shirzad, M. Sepidarkish, M. Hossein-Boroujerdi, and M. J. Hosseinzadeh-Attar. 2018. Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: A randomised double-blind placebo-controlled trial. The British Journal of Nutrition 119 (4):398–406. doi: 10.1017/S0007114517003920.
  • Kasińska, M. A., and J. Drzewoski. 2015. Effectiveness of probiotics in type 2 diabetes: A meta-analysis. Polish Archives of Internal Medicine 125 (11):803–13. doi: 10.20452/pamw.3156.
  • Ko, C. W., J. Qu, D. D. Black, and P. Tso. 2020. Regulation of intestinal lipid metabolism: Current concepts and relevance to disease. Nature Reviews. Gastroenterology & Hepatology 17 (3):169–83. doi: 10.1038/s41575-019-0250-7.
  • Kogure, G. S., I. P. Lopes, V. B. Ribeiro, M. C. Mendes, S. Kodato, C. Furtado, M. F. Silva de Sá, R. A. Ferriani, L. Lara, and R. Reis. 2020. The effects of aerobic physical exercises on body image among women with polycystic ovary syndrome. Journal of Affective Disorders 262:350–8. doi: 10.1016/j.jad.2019.11.025.
  • Liao, D., C. Zhong, C. Li, L. Mo, and Y. Liu. 2018. Meta-analysis of the effects of probiotic supplementation on glycemia, lipidic profiles, weight loss and C-reactive protein in women with polycystic ovarian syndrome. Minerva Medica 109 (6):479–87. doi: 10.23736/S0026-4806.18.05728-2.
  • Lindheim, L., M. Bashir, J. Münzker, C. Trummer, V. Zachhuber, B. Leber, A. Horvath, T. R. Pieber, G. Gorkiewicz, V. Stadlbauer, et al. 2017. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PloS One 12 (1):e0168390. doi: 10.1371/journal.pone.0168390.
  • Liu, R., C. Zhang, Y. Shi, F. Zhang, L. Li, X. Wang, Y. Ling, H. Fu, W. Dong, J. Shen, et al. 2017. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Frontiers in Microbiology 8:324. doi: 10.3389/fmicb.2017.00324.
  • Macut, D., J. Bjekic-Macut, D. Rahelic, and M. Doknic. 2017. Insulin and the polycystic ovary syndrome. Diabetes Research and Clinical Practice 130:163–70. doi: 10.1016/j.diabres.2017.06.011.
  • Meng, X., H. Y. Zhou, H. H. Shen, E. Lufumpa, X. M. Li, B. Guo, and B. Z. Li. 2019. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmunity Reviews 18 (5):455–75. doi: 10.1016/j.autrev.2019.03.006.
  • Moghetti, P. 2016. Insulin resistance and polycystic ovary syndrome. Current Pharmaceutical Design 22 (36):5526–34. doi: 10.2174/1381612822666160720155855.
  • Moher, D., L. Shamseer, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, and L. A. Stewart. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 4:1. doi: 10.1186/2046-4053-4-1.
  • Nasri, K., M. Jamilian, E. Rahmani, F. Bahmani, M. Tajabadi-Ebrahimi, and Z. Asemi. 2018. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. BMC Endocrine Disorders 18 (1):21 doi: 10.1186/s12902-018-0248-0.
  • Oberfroid, M., G. R. Gibson, L. Hoyles, A. L. McCartney, R. Rastall, I. Rowland, D. Wolvers, B. Watzl, H. Szajewska, B. Stahl, et al. 2010. Prebiotic effects: Metabolic and health benefits. British Journal of Nutrition 104 (Suppl 2):S1–S63. doi: 10.1017/S0007114510003363.
  • Ostadmohammadi, V., M. Jamilian, F. Bahmani, and Z. Asemi. 2019. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. Journal of Ovarian Research 12 (1):5. doi: 10.1186/s13048-019-0480-x.
  • Oulangé, C. L., A. L. Neves, J. Chilloux, J. K. Nicholson, and M. E. Dumas. 2016. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine 8 (1):42. doi: 10.1186/s13073-016-0303-2.
  • Pandey, K. R., S. R. Naik, and B. V. Vakil. 2015. Probiotics, prebiotics and synbiotics- a review. Journal of Food Science and Technology 52 (12):7577–87. doi: 10.1007/s13197-015-1921-1.
  • Patel, S. 2018. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology 182:27–36. doi: 10.1016/j.jsbmb.2018.04.008.
  • PCOS GREA. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19 (1):41–7. doi: 10.1093/humrep/deh098.
  • Qi, X., C. Yun, L. Sun, J. Xia, Q. Wu, Y. Wang, L. Wang, Y. Zhang, X. Liang, L. Wang, et al. 2019. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nature Medicine 25 (8):1225–33. doi: 10.1038/s41591-019-0509-0.
  • Sacerdote, A., P. Dave, V. Lokshin, and G. Bahtiyar. 2019. Type 2 diabetes mellitus, insulin resistance, and vitamin D. Current Diabetes Reports 19 (10):101. doi: 10.1007/s11892-019-1201-y.
  • Samimi, M., A. Dadkhah, H. Haddad Kashani, M. Tajabadi-Ebrahimi, E. Seyed Hosseini, and Z. Asemi. 2018. The effects of synbiotic supplementation on metabolic status in women with polycystic ovary syndrome: A randomized double-blind clinical trial. Probiotics and Antimicrobial Proteins 11 (4):1355–61. doi: 10.1007/s12602-018-9405-z.
  • Scheithauer, T. P., G. M. Dallinga-Thie, W. M. de Vos, M. Nieuwdorp, and D. H. van Raalte. 2016. Causality of small and large intestinal microbiota in weight regulation and insulin resistance. Molecular Metabolism 5 (9):759–70. doi: 10.1016/j.molmet.2016.06.002.
  • Schoeler, M., and R. Caesar. 2019. Dietary lipids, gut microbiota and lipid metabolism. Reviews in Endocrine & Metabolic Disorders 20 (4):461–72. doi: 10.1007/s11154-019-09512-0.
  • Schünemann, H. J., A. H. J. Schünemann, A. D. Oxman, J. Brozek, P. Glasziou, R. Jaeschke, G. E. Vist, J. W. Williams, R. Kunz, J. Craig, et al. 2008. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336 (7653):1106–10. doi: 10.1136/bmj.39500.677199.AE.
  • Seganfredo, F. B., C. A. Blume, M. Moehlecke, A. Giongo, D. S. Casagrande, J. Spolidoro, A. V. Padoin, B. D. Schaan, and C. C. Mottin. 2017. Weight-loss interventions and gut microbiota changes in overweight and obese patients: A systematic review. Obesity Reviews 18 (8):832–51. doi: 10.1111/obr.12541.
  • Sevda, G., P. Dehghan, S. Mohammad-Alizadeh Charandabi, A. Aliasgarzadeh, and M. Mirghafourvand. 2018. Effect of prebiotic on anthropometric indices in women with polycystic ovarian syndrome: A triple-blind, randomized, controlled clinical trial. Iranian Red Crescent Medical Journal. 20:e67270. doi: 10.5812/ircmj.67270.
  • Shabani, A., M. Noshadian, M. Jamilian, M. Chamani, S. Mohammadi, and Z. Asemi. 2018. The effects of a novel combination of selenium and probiotic on weight loss, glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome. Journal of Functional Foods 46:329–34. doi: 10.1016/j.jff.2018.04.071.
  • Shamasbi, S., P. Dehgan, S. Mohammad-Alizadeh Charandabi, A. Aliasgarzadeh, and M. Mirghafourvand. 2018. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: A randomized, triple-blind, controlled, clinical trial. European Journal of Nutrition 58 (2):629–40. doi: 10.1007/s00394-018-1648-7.
  • Shamasbi, S. G., S. Ghanbari-Homayi, and M. Mirghafourvand. 2020. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: A systematic review and meta-analysis. European Journal of Nutrition 59 (2):433–50. doi: 10.1007/s00394-019-02033-1.
  • Shoaei, T., M. Heidari-Beni, H. G. Tehrani, A. Feizi, A. Esmaillzadeh, and G. Askari. 2015. Effects of probiotic supplementation on pancreatic β-cell function and C-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. International Journal of Preventive Medicine 6:27. doi: 10.4103/2008-7802.153866.
  • Shorakae, S., S. Ranasinha, S. Abell, G. Lambert, E. Lambert, B. de Courten, and H. Teede. 2018. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clinical Endocrinology 89 (5):628–33. doi: 10.1111/cen.13808.
  • Shorakae, S., H. Teede, B. de Courten, G. Lambert, J. Boyle, and L. J. Moran. 2015. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Seminars in Reproductive Medicine 33 (4):257–69. doi: 10.1055/s-0035-1556568.
  • Stanley, S. A., L. Kelly, K. N. Latcha, S. F. Schmidt, X. Yu, A. R. Nectow, J. Sauer, J. P. Dyke, J. S. Dordick, and J. M. Friedman. 2016. Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism. Nature 531 (7596):647–50. doi: 10.1038/nature17183.
  • Tabrizi, R., M. Moosazadeh, K. B. Lankarani, M. Akbari, S. T. Heydari, F. Kolahdooz, and Z. Asemi. 2018. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Probiotics and Antimicrobial Proteins 10 (2):329–42. doi: 10.1007/s12602-017-9299-1.
  • Tabrizi, R., V. Ostadmohammadi, M. Akbari, K. B. Lankarani, S. Vakili, P. Peymani, M. Karamali, F. Kolahdooz, and Z. Asemi. 2019. The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Probiotics and Antimicrobial Proteins 11(2): 729–742. doi: 10.1007/s12602-019-09559-0.
  • Teede, H., A. Deeks, and L. Moran. 2010. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine 8 (41):41. doi: 10.1186/1741-7015-8-41.
  • Trost, S. G., N. Owen, A. E. Bauman, J. F. Sallis, and W. Brown. 2002. Correlates of adults' participation in physical activity: Review and update. Medicine & Science in Sports & Exercise 34 (12):1996–2001. 10.1097/00005768-200212000-00020.
  • Vallianou, N. G., T. Stratigou, and S. Tsagarakis. 2018. Microbiome and diabetes: Where are we now? Diabetes Research and Clinical Practice 146:111–8. doi: 10.1016/j.diabres.2018.10.008.
  • van de Wouw, M., H. Schellekens, T. G. Dinan, and J. F. Cryan. 2017. Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite. The Journal of Nutrition 147 (5):727–45. doi: 10.3945/jn.116.240481.
  • Viollet, B., B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli. 2012. Cellular and molecular mechanisms of metformin: An overview. Clinical Science (London, England : 1979) 122 (6):253–70. doi: 10.1042/CS20110386.
  • Xue, J., X. Li, P. Liu, K. Li, L. Sha, X. Yang, L. Zhu, Z. Wang, Y. Dong, L. Zhang, et al. 2019. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. Endocrine Journal 66 (10):859–70. doi: 10.1507/endocrj.EJ18-0567.
  • Yamashiro, Y. 2017. Gut Microbiota in Health and Disease. Annals of Nutrition & Metabolism 71 (3–4):242–6. doi: 10.1159/000481627.
  • Yoo, J. Y., and S. S. Kim. 2016. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients 8 (3):173. doi: 10.3390/nu8030173.
  • Zahra, E., R. Barati-Boldaji, N. R. Brett, J. O. T. de Zepetnek, N. Bellissimo, S. Babajafari, and Z. Sohrabi. 2019. The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: A randomized, triple-blinded, controlled trial. Journal of Endocrinological Investigation 43 (4):539–48. doi: 10.1007/s40618-019-01139-x.
  • Zeng, B., Z. Lai, L. Sun, Z. Zhang, J. Yang, Z. Li, J. Lin, and Z. Zhang. 2019. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): A pilot study. Research in Microbiology 170 (1):43–52. doi: 10.1016/j.resmic.2018.09.002.
  • Zhu, Z., X. Pengbin, and H. Yaqiong. 2020. Effects of vitamin D and probiotics supplementation on bacterial diversity, metabolism and hormone level in patients with polycystic ovary syndrome. Chinese Journal of Microecology 32 (3):317–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.